PK-PD Modeling Suggests Tumor Heterogeneity Limits Preclinical to Clinical Translation of Enzalutamide in Prostate Cancer
{{output}}
Purpose: To assess the translational performance of preclinical models to anticipate enzalutamide clinical efficacy in prostate cancer using a cross-species physiologically-based pharmacokinetic (PBPK)-pharmacodynamic (PD) model ... ...
